|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 498/04 | |
| C07D 498/14 | |||
| C07D 519/00 | |||
| A61K 31/4162 | |||
| A61K 31/4188 | |||
| A61K 31/4196 | |||
| A61P 35/00 |
| (11) | Number of the document | 2711368 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13193562.9 |
| Date of filing the European patent application | 2010-09-27 | |
| (97) | Date of publication of the European application | 2014-03-26 |
| (45) | Date of publication and mention of the grant of the patent | 2016-03-23 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 246381 P | 2009-09-28 | US | |
| 330685 P | 2010-05-03 | US |
| (72) |
Blaquiere, Nicole, US
Do, Steven, US
Dudley, Danette, US
Folkes, Adrian J., GB
Heald, Robert, GB
Heffron, Timothy, US
Jones, Mark, GB
Kolesnikov, Aleksandr, US
Ndubaku, Chudi, US
Olivero, Alan G., US
Price, Stephen, GB
Staben, Steven, US
Wang, Lan, US
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (54) | Benzoxazepin PI3K inhibitor compounds and methods of use |
| Benzoxazepin PI3K inhibitor compounds and methods of use |